Green Spirit Industries Inc. Assumes Prequalified License to Medicinal Cannabis Dispensary in Puerto Rico

DORADO, Puerto Rico, April 10, 2018 -- Green Spirit Industries Inc. (OTCPink:GSRX) (“Green Spirit” or, the “Company”), through its wholly-owned subsidiary, Project 1493 LLC, has completed title transfer of the prequalified license for Medicinal Cannabis Establishment No. 2017-08-0162 from Healing Herbs Corp. to Green Spirit Industries, Inc.  The Company plans to develop the location to do business as a Green Spirit RX medicinal cannabis dispensary, subject to all inspections, and issuance of the requisite establishment license by the Department of Health of Puerto Rico.

The pre-approved license is for a dispensary to be located at Ave. César González #508, San Juan.  Last week, the Company announced the opening of the first Green Spirit RX medicinal cannabis dispensary in Puerto Rico, located in Dorado (Green Spirit RX Dorado).  The Company currently has three other locations in various stages of preparation on the island; one in Carolina, one in Fajardo, and another in San Juan.

During the first quarter of 2018, Green Spirit announced its entry into California’s cannabis cultivation and extraction business via a joint venture with Sunset Connect SF Inc. (Sunset Connect), as well as its acquisition of a majority stake in California-based cannabinoid products manufacturer Spirulinex, LLC. (Spirulinex).  Earlier this month, the Company announced its acquisition of The Green Room (The Green Room) a cannabis dispensary and delivery operation located in Point Arena, Mendocino County, California.

About Green Spirit Industries Inc.
Green Spirit Industries Inc. (OTC Pink:GSRX), through its subsidiaries, is in the business of acquiring, developing and operating retail cannabis dispensaries, and is in the process of expanding its business to include the cultivation, extraction, manufacture and delivery of cannabis and cannabinoid products.

Forward-Looking Statements

This press release contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and other publicly available information.

Contact:

Paul Gendreau
PGPR
[email protected]
678-807-7945